In leukemia cells, the inhibition of the STAT3 pathway can promote the intracellular accumulation of Adriamycin and down‐regulate the expression levels of MDR1 and MRP1, thus increasing drug sensitivity [36]. This evidence concerns the gene STAT3 and leukemia.